Alexandria Pharmaceuticals posts 54% profit hike in FY19/20 initial results

Cairo – Mubasher: The unaudited financial results of Alexandria Co. for Pharmaceuticals and Chemical Industries showed a 54% year-on-year (YoY) growth in its net profits to EGP 173.8 million in fiscal year 2019/2020 from EGP 112.8 million.

The company’s sales increased to EGP 1.02 billion in the 12-month period ended on 30 June, compared to EGP 829 million a year earlier, according to a bourse disclosure on Wednesday.

It is worth mentioning that during the first 11 months of FY19/20, the Egyptian firm achieved net profits of EGP 150.56 million, up from EGP 112.6 million in the year-ago period.

Source: Mubasher

Disclaimer: The content of this article is syndicated or provided to this website from an external third party provider. We are not responsible for, and do not control, such external websites, entities, applications or media publishers. The body of the text is provided on an “as is” and “as available” basis and has not been edited in any way. Neither we nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this article. Read our full disclaimer policy here.